On 4/7/2017, Shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) closed at $14.34 in last trading day. After noting the initial trading entry at $14.75, it reached to a day’s high of $15.00 and moved to a day’s low of $14.14. The recent daily volume was 1.8 million as contrast to it’s an average volume of 358.55 thousand.
The last close of the Albany Molecular Research, Inc. stock reflects that it traded -7.74% from its 50-day moving average of $15.54. The stock traded below -13.82% to its 200-day MA of $16.64. Furthermore, it moved lower -25.89% from its 52-week high of $19.35 and +15.18% up from $12.45, which is 52-week low of the stock.
Albany Molecular Research, Inc.’s (AMRI) moved with shift of 2.21% in the past week. Over the last three months, the shares of the company have changed -23.97% and performed -16.87% over the last six months. The stock currently has Monthly Volatility of 3.60% and Weekly Volatility of 3.54%.
Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. The company’s Discovery and Development Services segment offers services from target identification tools to investigational new drug enabling activities, such as diverse chemistry library design and synthesis, high throughput and high content screening, medicinal chemistry, and biology, as well as pharmacology, including drug metabolism and pharmacokinetics. It also provides analytical chemistry and testing services for drug discovery, and pharmaceutical development and manufacturing; and chemical development technologies to promote the solutions for route development from late lead optimization to commercial manufacturing. Its Active Pharmaceutical Ingredients segment offers chemical synthesis and manufacturing services in accordance with current good manufacturing practice (cGMP) regulations. The company’s Drug Product segment provides integrated pharmaceutical drug development programs and services, including process research and development, pre-formulation and formulation development, and GLP bioanalytical and separation sciences; formulation development services for solid dosage, solution, suspension, topicals, and injectables; and cGMP contract manufacturing services in sterile syringe and vial filling using specialized technologies, including lyophilization. Its Fine Chemical segment provides lab to commercial scale synthesis of reagents, and various compounds to the pharmaceutical, agrochemical, detergent, and cosmetic industries. The company serves pharmaceutical and biotechnology companies; government research entities and non-profit organizations; and agriculture, fine chemicals, contract chemical manufacturing, medical devices, and flavoring and cosmetics businesses. The company was founded in 1991 and is headquartered in Albany, New York.
Children’s Place, Inc. (NASDAQ:PLCE) finalized the last transaction at value of $109.55, with a daily change of -2.36% or -2.65 points. The company maintained volume of 522.54 thousand shares. In past trading day, the stock hit the maximum price of $111.95 and touched to minimum value of $108.90. It has a market cap of $ 1.93B.
As of last trade close, the stock is trading downside -10.90% from its one year high of $122.95 and moved +63.70% upward from $66.92, which is one year low of the stock.
The stock traded above +2.75% from its 50-day moving average of $106.62. Furthermore, the stock moved up +15.83% to its 200-day MA of $ 94.58.
During the last month, The Children’s Place, Inc.’s (PLCE) has changed -5.54% and performed 43.17% over the last 6 months. The mean rating score for this stock is at 2.10. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 2.59% in recent month and observed Weekly Volatility of 3.86%.
The Children’s Place, Inc. operates as a children’s specialty apparel retailer. The company operates through two segments, The Children’s Place U.S. and The Children’s Place International. It sells apparel, accessories, footwear, and other items for children; and designs, contracts to manufacture, and sells merchandise under the proprietary The Children’s Place, Place, and Baby Place brand names. As of January 28, 2017, the company operated 1,039 stores in the United States, Canada, and Puerto Rico; and 150 international points of distribution operated by its 6 franchise partners in 17 countries. It also sells its products through childrensplace.com, an online store. The company was formerly known as The Children’s Place Retail Stores, Inc. and changed its name to The Children’s Place, Inc. in June 2014. The Children’s Place, Inc. was founded in 1969 and is based in Secaucus, New Jersey.